Journal Article

The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation

A. Capucci, G.Q. Villani, N. Marrazzo and M. Piepoli

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 3, issue suppl_P, pages P47-P52
Published in print November 2001 | ISSN: 1520-765X
Published online November 2001 | e-ISSN: 1554-2815 | DOI: http://dx.doi.org/10.1016/S1520-765X(01)90072-0
The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation

Show Summary Details

Preview

Atrial fibrillation (AF) is the most common sustained arrhythmia. Current therapies, including pharmacological treatment, radiofrequency ablation and implantable devices, showed significant limitation when used alone. Recently a number of combined therapies (hybrid therapy approach) were suggested. Radiofrequency ablation may improve the efficacy of drugs, pacing and automatic internal defibrillators. Antiarrhythmic drugs may play a similar role, enhancing preventive atrial pacing effectiveness as well as sinus rhythm restoration capabilities of cardioversion shocks and antitachycardia pacing. The availability of a wide range of therapeutic options suggests that the approach to the treatment of AF needs to be selected on an individual basis.

Keywords: Atrial fibrillation; antiarrhythmic drugs; atrial cardioversion; radiofrequency ablation; dual chamber pacing; implantable cardioverter-defibrillator

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.